Back to search

Article

Loss of Anti-Spike Antibodies Following mRNA Vaccination for COVID-19 Among Patients with Multiple Myeloma

2022-11-18

Abstract excerpt

<h4>Background: </h4> Multiple myeloma (MM) patients have variable responses to mRNA vaccination to COVID-19. Little is known regarding their vaccine-induced antibody levels over time. <h4>Methods: </h4> We monitored spike IgG antibody levels over 24 weeks among a subset of 18 MM patients who showed a full response after two mRNA vaccinations. MM patients had a more rapid decline in antibody levels as compared to...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
07fee396-a3cb-522d-9973-ea638959e292
DOI
10.22541/au.166879031.16384547/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Loss of Anti-Spike Antibodies Following mRNA Vaccination for COVID-19 Among Patients with Multiple MyelomaDOI 10.22541/au.166879031.16384547/v1
Cellular Mechanisms Associated with Sub-Optimal Immune Responses to SARS-CoV-2 Bivalent Booster Vaccination in Patients with Multiple MyelomaSemantic proximity
Impact of Omicron variant on the response to SARS-CoV-2 mRNA Vaccination in multiple myelomaSemantic proximity
Fatal breakthrough infection after anti-BCMA CAR-T therapy highlights suboptimal immune response to SARS-CoV-2 vaccination in myeloma patientsSemantic proximity
Anti-spike T-cell and Antibody Responses to SARS-CoV-2 mRNA Vaccines in Patients with Hematologic MalignanciesSemantic proximity
Longitudinal Vaccine-Induced Humoral Immune Response in Cancer PatientsSemantic proximity
Neutralizing anti-spike monoclonal antibodies for COVID-19 in vulnerable populations: lessons learned and future directions.Semantic proximity
Three-dose mRNA-1273 vaccination schedule: sufficient antibody response in majority of immunocompromised hematology patientsSemantic proximity
The immune response to Covid-19 mRNA vaccination among Lymphoma patients receiving anti-CD20 treatmentSemantic proximity
Divergence of variant binding/neutralizing antibodies following SARS-CoV-2 booster vaccines in myeloma: Impact of hybrid immunitySemantic proximity
Divergence of variant binding/neutralizing antibodies following SARS-CoV-2 booster vaccines in myeloma: Impact of hybrid immunitySemantic proximity
Class switching toward IgG4 six months after primary mRNA-based COVID-19 vaccination in kidney patientsSemantic proximity
Covid-19 vaccination in patients with multiple myeloma: Focus on immune response.Semantic proximity
Select a neighboring publication to make it the new centre.